Ann: Letter to Shareholders from the Board of Ave, page-15

re: Ann: Letter to Shareholders from the Boar... The problem with this "ask the FDA" scenario is that the FDA will craft a response that kicks responsibility for what to do next right back to AVX management, whoever that might be.

There will be just that little firefly glimmer of hope in there and that will keep certain shareholders pumped, and just enough realism to convey the opposite message to others. Nothing is likely to be conclusively resolved by this FDA consultation strategy.